世界のアッシャー症候群治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Usher Syndrome Threapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5003
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、87ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、アッシャー症候群治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（NT-501、QRX-411、QRX-421、SAR-421869、その他）、用途別市場規模（クリニック、病院、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・アッシャー症候群治療薬の市場動向
・企業の競争状況、市場シェア
・アッシャー症候群治療薬の種類別市場規模と予測2016-2027（NT-501、QRX-411、QRX-421、SAR-421869、その他）
・アッシャー症候群治療薬の用途別市場規模と予測2016-2027（クリニック、病院、その他）
・アッシャー症候群治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・アッシャー症候群治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・アッシャー症候群治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・アッシャー症候群治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・アッシャー症候群治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Amgen Inc、Editas Medicine Inc、ProQR Therapeutics NV、Sanofi）
・結論

Market Analysis and Insights: Global Usher Syndrome Threapeutics Market
The global Usher Syndrome Threapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Usher Syndrome Threapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Usher Syndrome Threapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Usher Syndrome Threapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Usher Syndrome Threapeutics market.

Global Usher Syndrome Threapeutics Scope and Market Size
Usher Syndrome Threapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Usher Syndrome Threapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
NT-501
QRX-411
QRX-421
SAR-421869
Others

Segment by Application
Clinic
Hospital
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Amgen Inc
Editas Medicine Inc
ProQR Therapeutics NV
Sanofi

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Usher Syndrome Threapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 NT-501
1.2.3 QRX-411
1.2.4 QRX-421
1.2.5 SAR-421869
1.2.6 Others
1.3 Market by Application
1.3.1 Global Usher Syndrome Threapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Usher Syndrome Threapeutics Market Perspective (2016-2027)
2.2 Usher Syndrome Threapeutics Growth Trends by Regions
2.2.1 Usher Syndrome Threapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Usher Syndrome Threapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Usher Syndrome Threapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Usher Syndrome Threapeutics Industry Dynamic
2.3.1 Usher Syndrome Threapeutics Market Trends
2.3.2 Usher Syndrome Threapeutics Market Drivers
2.3.3 Usher Syndrome Threapeutics Market Challenges
2.3.4 Usher Syndrome Threapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Usher Syndrome Threapeutics Players by Revenue
3.1.1 Global Top Usher Syndrome Threapeutics Players by Revenue (2016-2021)
3.1.2 Global Usher Syndrome Threapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Usher Syndrome Threapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Usher Syndrome Threapeutics Revenue
3.4 Global Usher Syndrome Threapeutics Market Concentration Ratio
3.4.1 Global Usher Syndrome Threapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Usher Syndrome Threapeutics Revenue in 2020
3.5 Usher Syndrome Threapeutics Key Players Head office and Area Served
3.6 Key Players Usher Syndrome Threapeutics Product Solution and Service
3.7 Date of Enter into Usher Syndrome Threapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Usher Syndrome Threapeutics Breakdown Data by Type
4.1 Global Usher Syndrome Threapeutics Historic Market Size by Type (2016-2021)
4.2 Global Usher Syndrome Threapeutics Forecasted Market Size by Type (2022-2027)

5 Usher Syndrome Threapeutics Breakdown Data by Application
5.1 Global Usher Syndrome Threapeutics Historic Market Size by Application (2016-2021)
5.2 Global Usher Syndrome Threapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Usher Syndrome Threapeutics Market Size (2016-2027)
6.2 North America Usher Syndrome Threapeutics Market Size by Type
6.2.1 North America Usher Syndrome Threapeutics Market Size by Type (2016-2021)
6.2.2 North America Usher Syndrome Threapeutics Market Size by Type (2022-2027)
6.2.3 North America Usher Syndrome Threapeutics Market Size by Type (2016-2027)
6.3 North America Usher Syndrome Threapeutics Market Size by Application
6.3.1 North America Usher Syndrome Threapeutics Market Size by Application (2016-2021)
6.3.2 North America Usher Syndrome Threapeutics Market Size by Application (2022-2027)
6.3.3 North America Usher Syndrome Threapeutics Market Size by Application (2016-2027)
6.4 North America Usher Syndrome Threapeutics Market Size by Country
6.4.1 North America Usher Syndrome Threapeutics Market Size by Country (2016-2021)
6.4.2 North America Usher Syndrome Threapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Usher Syndrome Threapeutics Market Size (2016-2027)
7.2 Europe Usher Syndrome Threapeutics Market Size by Type
7.2.1 Europe Usher Syndrome Threapeutics Market Size by Type (2016-2021)
7.2.2 Europe Usher Syndrome Threapeutics Market Size by Type (2022-2027)
7.2.3 Europe Usher Syndrome Threapeutics Market Size by Type (2016-2027)
7.3 Europe Usher Syndrome Threapeutics Market Size by Application
7.3.1 Europe Usher Syndrome Threapeutics Market Size by Application (2016-2021)
7.3.2 Europe Usher Syndrome Threapeutics Market Size by Application (2022-2027)
7.3.3 Europe Usher Syndrome Threapeutics Market Size by Application (2016-2027)
7.4 Europe Usher Syndrome Threapeutics Market Size by Country
7.4.1 Europe Usher Syndrome Threapeutics Market Size by Country (2016-2021)
7.4.2 Europe Usher Syndrome Threapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Usher Syndrome Threapeutics Market Size (2016-2027)
8.2 Asia-Pacific Usher Syndrome Threapeutics Market Size by Type
8.2.1 Asia-Pacific Usher Syndrome Threapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Usher Syndrome Threapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Usher Syndrome Threapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Usher Syndrome Threapeutics Market Size by Application
8.3.1 Asia-Pacific Usher Syndrome Threapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Usher Syndrome Threapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Usher Syndrome Threapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Usher Syndrome Threapeutics Market Size by Region
8.4.1 Asia-Pacific Usher Syndrome Threapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Usher Syndrome Threapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Usher Syndrome Threapeutics Market Size (2016-2027)
9.2 Latin America Usher Syndrome Threapeutics Market Size by Type
9.2.1 Latin America Usher Syndrome Threapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Usher Syndrome Threapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Usher Syndrome Threapeutics Market Size by Type (2016-2027)
9.3 Latin America Usher Syndrome Threapeutics Market Size by Application
9.3.1 Latin America Usher Syndrome Threapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Usher Syndrome Threapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Usher Syndrome Threapeutics Market Size by Application (2016-2027)
9.4 Latin America Usher Syndrome Threapeutics Market Size by Country
9.4.1 Latin America Usher Syndrome Threapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Usher Syndrome Threapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Usher Syndrome Threapeutics Market Size (2016-2027)
10.2 Middle East & Africa Usher Syndrome Threapeutics Market Size by Type
10.2.1 Middle East & Africa Usher Syndrome Threapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Usher Syndrome Threapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Usher Syndrome Threapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Usher Syndrome Threapeutics Market Size by Application
10.3.1 Middle East & Africa Usher Syndrome Threapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Usher Syndrome Threapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Usher Syndrome Threapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Usher Syndrome Threapeutics Market Size by Country
10.4.1 Middle East & Africa Usher Syndrome Threapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Usher Syndrome Threapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Amgen Inc
11.1.1 Amgen Inc Company Details
11.1.2 Amgen Inc Business Overview
11.1.3 Amgen Inc Usher Syndrome Threapeutics Introduction
11.1.4 Amgen Inc Revenue in Usher Syndrome Threapeutics Business (2016-2021)
11.1.5 Amgen Inc Recent Development
11.2 Editas Medicine Inc
11.2.1 Editas Medicine Inc Company Details
11.2.2 Editas Medicine Inc Business Overview
11.2.3 Editas Medicine Inc Usher Syndrome Threapeutics Introduction
11.2.4 Editas Medicine Inc Revenue in Usher Syndrome Threapeutics Business (2016-2021)
11.2.5 Editas Medicine Inc Recent Development
11.3 ProQR Therapeutics NV
11.3.1 ProQR Therapeutics NV Company Details
11.3.2 ProQR Therapeutics NV Business Overview
11.3.3 ProQR Therapeutics NV Usher Syndrome Threapeutics Introduction
11.3.4 ProQR Therapeutics NV Revenue in Usher Syndrome Threapeutics Business (2016-2021)
11.3.5 ProQR Therapeutics NV Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Usher Syndrome Threapeutics Introduction
11.4.4 Sanofi Revenue in Usher Syndrome Threapeutics Business (2016-2021)
11.4.5 Sanofi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Usher Syndrome Threapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of NT-501
Table 3. Key Players of QRX-411
Table 4. Key Players of QRX-421
Table 5. Key Players of SAR-421869
Table 6. Key Players of Others
Table 7. Global Usher Syndrome Threapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Usher Syndrome Threapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Usher Syndrome Threapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Usher Syndrome Threapeutics Market Share by Regions (2016-2021)
Table 11. Global Usher Syndrome Threapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Usher Syndrome Threapeutics Market Share by Regions (2022-2027)
Table 13. Usher Syndrome Threapeutics Market Trends
Table 14. Usher Syndrome Threapeutics Market Drivers
Table 15. Usher Syndrome Threapeutics Market Challenges
Table 16. Usher Syndrome Threapeutics Market Restraints
Table 17. Global Usher Syndrome Threapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Usher Syndrome Threapeutics Market Share by Players (2016-2021)
Table 19. Global Top Usher Syndrome Threapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Usher Syndrome Threapeutics as of 2020)
Table 20. Ranking of Global Top Usher Syndrome Threapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Usher Syndrome Threapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Usher Syndrome Threapeutics Product Solution and Service
Table 24. Date of Enter into Usher Syndrome Threapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Usher Syndrome Threapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Usher Syndrome Threapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Usher Syndrome Threapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Usher Syndrome Threapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Usher Syndrome Threapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Usher Syndrome Threapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Usher Syndrome Threapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Usher Syndrome Threapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Usher Syndrome Threapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Usher Syndrome Threapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Usher Syndrome Threapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Usher Syndrome Threapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Usher Syndrome Threapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Usher Syndrome Threapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Usher Syndrome Threapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Usher Syndrome Threapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Usher Syndrome Threapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Usher Syndrome Threapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Usher Syndrome Threapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Usher Syndrome Threapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Usher Syndrome Threapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Usher Syndrome Threapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Usher Syndrome Threapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Usher Syndrome Threapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Usher Syndrome Threapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Usher Syndrome Threapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Usher Syndrome Threapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Usher Syndrome Threapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Usher Syndrome Threapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Usher Syndrome Threapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Usher Syndrome Threapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Usher Syndrome Threapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Usher Syndrome Threapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Usher Syndrome Threapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Usher Syndrome Threapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Usher Syndrome Threapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Usher Syndrome Threapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Usher Syndrome Threapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Amgen Inc Company Details
Table 65. Amgen Inc Business Overview
Table 66. Amgen Inc Usher Syndrome Threapeutics Product
Table 67. Amgen Inc Revenue in Usher Syndrome Threapeutics Business (2016-2021) & (US$ Million)
Table 68. Amgen Inc Recent Development
Table 69. Editas Medicine Inc Company Details
Table 70. Editas Medicine Inc Business Overview
Table 71. Editas Medicine Inc Usher Syndrome Threapeutics Product
Table 72. Editas Medicine Inc Revenue in Usher Syndrome Threapeutics Business (2016-2021) & (US$ Million)
Table 73. Editas Medicine Inc Recent Development
Table 74. ProQR Therapeutics NV Company Details
Table 75. ProQR Therapeutics NV Business Overview
Table 76. ProQR Therapeutics NV Usher Syndrome Threapeutics Product
Table 77. ProQR Therapeutics NV Revenue in Usher Syndrome Threapeutics Business (2016-2021) & (US$ Million)
Table 78. ProQR Therapeutics NV Recent Development
Table 79. Sanofi Company Details
Table 80. Sanofi Business Overview
Table 81. Sanofi Usher Syndrome Threapeutics Product
Table 82. Sanofi Revenue in Usher Syndrome Threapeutics Business (2016-2021) & (US$ Million)
Table 83. Sanofi Recent Development
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Usher Syndrome Threapeutics Market Share by Type: 2020 VS 2027
Figure 2. NT-501 Features
Figure 3. QRX-411 Features
Figure 4. QRX-421 Features
Figure 5. SAR-421869 Features
Figure 6. Others Features
Figure 7. Global Usher Syndrome Threapeutics Market Share by Application: 2020 VS 2027
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Others Case Studies
Figure 11. Usher Syndrome Threapeutics Report Years Considered
Figure 12. Global Usher Syndrome Threapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Usher Syndrome Threapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Usher Syndrome Threapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Usher Syndrome Threapeutics Market Share by Regions (2022-2027)
Figure 16. Global Usher Syndrome Threapeutics Market Share by Players in 2020
Figure 17. Global Top Usher Syndrome Threapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Usher Syndrome Threapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Usher Syndrome Threapeutics Revenue in 2020
Figure 19. Global Usher Syndrome Threapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Usher Syndrome Threapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Usher Syndrome Threapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Usher Syndrome Threapeutics Market Share by Type (2016-2027)
Figure 23. North America Usher Syndrome Threapeutics Market Share by Application (2016-2027)
Figure 24. North America Usher Syndrome Threapeutics Market Share by Country (2016-2027)
Figure 25. United States Usher Syndrome Threapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Usher Syndrome Threapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Usher Syndrome Threapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Usher Syndrome Threapeutics Market Share by Type (2016-2027)
Figure 29. Europe Usher Syndrome Threapeutics Market Share by Application (2016-2027)
Figure 30. Europe Usher Syndrome Threapeutics Market Share by Country (2016-2027)
Figure 31. Germany Usher Syndrome Threapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Usher Syndrome Threapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Usher Syndrome Threapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Usher Syndrome Threapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Usher Syndrome Threapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Usher Syndrome Threapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Usher Syndrome Threapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Usher Syndrome Threapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Usher Syndrome Threapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Usher Syndrome Threapeutics Market Share by Region (2016-2027)
Figure 41. China Usher Syndrome Threapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Usher Syndrome Threapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Usher Syndrome Threapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Usher Syndrome Threapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Usher Syndrome Threapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Usher Syndrome Threapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Usher Syndrome Threapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Usher Syndrome Threapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Usher Syndrome Threapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Usher Syndrome Threapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Usher Syndrome Threapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Usher Syndrome Threapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Usher Syndrome Threapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Usher Syndrome Threapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Usher Syndrome Threapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Usher Syndrome Threapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Usher Syndrome Threapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Usher Syndrome Threapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Usher Syndrome Threapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Amgen Inc Revenue Growth Rate in Usher Syndrome Threapeutics Business (2016-2021)
Figure 61. Editas Medicine Inc Revenue Growth Rate in Usher Syndrome Threapeutics Business (2016-2021)
Figure 62. ProQR Therapeutics NV Revenue Growth Rate in Usher Syndrome Threapeutics Business (2016-2021)
Figure 63. Sanofi Revenue Growth Rate in Usher Syndrome Threapeutics Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

以下、関連資料のご紹介

アッシャー症候群治療法のグローバル市場調査 2019年

Global Usher Syndrome Threapeutics Market Professional Survey Report 2019
QYR9NV13987 2019年11月16日 106Pages
※本調査レポートは、アッシャー症候群治療法の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、NT-501、QRX-411、QRX-421、SAR-421869、...

アッシャー症候群治療法のグローバル市場調査 2019年

世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年）

Global Hepatorenal Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4305 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、肝腎症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヘパトレン、テルリバズ、グリプレシン、ルカシン、その他）、用途別市場規模（1型肝腎症候群、2型肝腎症候群）、主要地域別市場規模（北米、アメ...

世界のウェスト症候群市場規模・現状・予測（2021年-2027年）

Global West Syndrome Market Size, Status and Forecast 2021-2027
QFJ1-5039 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、ウェスト症候群の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療法、新薬）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の骨髄異形成症候群分子診断市場規模・現状・予測（2021年-2027年）

Global Molecular Diagnosis of Myelodysplastic Syndrome Market Size, Status and Forecast 2021-2027
QFJ1-4519 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、骨髄異形成症候群分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模...

世界のブルガダ症候群市場規模・現状・予測（2021年-2027年）

Global Brugada Syndrome Market Size, Status and Forecast 2021-2027
QFJ1-5638 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、ブルガダ症候群の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（診断、治療）、用途別市場規模（大人、子供）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米...

世界のレノックス・ガストー症候群治療市場規模・現状・予測（2021年-2027年）

Global Lennox-Gastaut Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4422 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、レノックス・ガストー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非外科的治療、外科的治療）、用途別市場規模（発作、眼球異常、脳波所見、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界の過敏性腸症候群（IBS）処方薬市場規模・現状・予測（2021年-2027年）

Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, Status and Forecast 2021-2027
QFJ1-6000 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、過敏性腸症候群（IBS）処方薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（IBS-D薬、IBS-C薬、その他）、用途別市場規模（女性用、男性用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界の閉塞性細気管支炎症候群市場規模・現状・予測（2021年-2027年）

Global Bronchiolitis Obliterans Syndrome Market Size, Status and Forecast 2021-2027
QFJ1-3944 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、閉塞性細気管支炎症候群の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（吸入式、経口式）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界のグッドパスチャー症候群治療市場規模・現状・予測（2021年-2027年）

Global Goodpasture Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5758 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、グッドパスチャー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、免疫抑制剤、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

アッシャー症候群治療法のグローバル市場調査 2019年 The global Usher Syndrome Threapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Usher Syndrome Threapeutics volume and value at global level, regional level and company level. From a global p…
アッシャー症候群治療法のグローバル市場調査 2019年 The global Usher Syndrome Threapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Usher Syndrome Threapeutics volume and value at global level, regional level and company level. From a global p…
世界のウェスト症候群市場規模・現状・予測（2021年-2027年） West syndrome is an age-related specific epileptic encephalopathy due to multiple and diverse causes. It is characterized by a unique type of seizure called epileptic (infantile) spasms and gross EEG abnormalities of hypsarrhythmia. Usually, West syndrome consists of a characteristic triad: infantil…
世界の閉塞性細気管支炎症候群市場規模・現状・予測（2021年-2027年） Bronchiolitis obliterans may result from lung injury caused by a variety of different chemicals and respiratory infections. Inhaled chemicals known to irritate the lungs and lead to the condition include chlorine; ammonia; oxides of nitrogen or sulfur dioxide; welding fumes; or food flavoring fumes …
世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年） Hepatorenal syndrome (often abbreviated HRS) is a life-threatening medical condition that consists of rapid deterioration in kidney function in individuals with cirrhosis or fulminant liver failure. HRS is usually fatal unless a liver transplant is performed, although various treatments, such as dia…